tiprankstipranks
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market

Taysha Gene Therapies (TSHA) Financial Statements

Compare
969 Followers

Taysha Gene Therapies Financial Overview

Taysha Gene Therapies's market cap is currently $395.65M. The company's EPS TTM is $-0.38; its P/E ratio is ―; Taysha Gene Therapies is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 8.33M$ 15.45M$ 2.50M$ 0.00$ 0.00
Gross Profit$ 8.33M$ 15.45M$ 15.00K$ -492.00K$ -9.00K
Operating Income$ -91.46M$ -72.44M$ -162.45M$ -173.27M$ -43.00M
EBITDA$ -87.95M$ -105.20M$ -159.73M$ -172.78M$ -42.99M
Net Income$ -89.30M$ -111.57M$ -169.58M$ -175.46M$ -43.00M
Balance Sheet
Cash & Short-Term Investments$ 139.04M$ 143.94M$ 87.88M$ 149.10M$ 251.25M
Total Assets$ 160.36M$ 172.73M$ 126.28M$ 213.96M$ 258.88M
Total Debt$ 17.36M$ 61.11M$ 59.93M$ 63.09M$ 0.00
Net Debt$ -121.67M$ -82.83M$ -27.95M$ -86.01M$ -251.25M
Total Liabilities$ 88.84M$ 97.79M$ 125.33M$ 118.57M$ 7.58M
Stockholders' Equity$ 71.53M$ 74.94M$ 949.00K$ 95.38M$ 251.30M
Cash Flow
Free Cash Flow$ -81.60M$ -80.39M$ -113.26M$ -138.60M$ -39.81M
Operating Cash Flow$ -81.22M$ -73.02M$ -88.39M$ -117.04M$ -30.73M
Investing Cash Flow$ -363.00K$ -7.35M$ -24.93M$ -21.55M$ -9.08M
Financing Cash Flow$ 76.68M$ 136.39M$ 52.10M$ 39.08M$ 291.06M
Currency in USD

Taysha Gene Therapies Earnings and Revenue History

Taysha Gene Therapies Debt to Assets

Taysha Gene Therapies Cash Flow

Taysha Gene Therapies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis